Trifluridine/Tipiracil + Fruquintinib Versus Trifluridine/Tipiracil Alone for Metastatic Oeso-gastric Adenocarcinoma

NCT07270991 · clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
324
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Federation Francophone de Cancerologie Digestive

Collaborators